Tang-du Hospital
Clinical trials sponsored by Tang-du Hospital, explained in plain language.
-
New combo aims to shrink lung tumors before surgery
Disease control Recruiting nowThis study tests whether a targeted drug (ensartinib) combined with standard chemotherapy can shrink ALK-positive lung cancer tumors before surgery. About 20 adults with stage II-IIIB lung cancer will receive the combo for 9 weeks, then have their tumor removed. Researchers will …
Phase: PHASE1, PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Could a rheumatoid arthritis drug help heal traumatic brain injuries?
Disease control Recruiting nowThis study tests whether baricitinib, a drug used for arthritis, can help people recover from moderate to severe traumatic brain injuries that involve bleeding in the brain. About 100 adults will receive the drug or a placebo within 24 hours of injury. The main goal is to see if …
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
New drug combo shows promise for tough esophageal cancer
Disease control Recruiting nowThis trial tests a new drug (AK112) combined with standard chemotherapy given before surgery for people with locally advanced esophageal cancer. The goal is to see if this approach can shrink tumors more effectively and improve outcomes. About 45 adults aged 18-75 with resectable…
Phase: PHASE1, PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
New hope for elderly lung cancer patients: single-drug immunotherapy trial launches
Disease control Recruiting nowThis study tests a drug called serplulimab in people aged 65 and older with advanced non-small cell lung cancer that has high PD-L1 levels. The goal is to see if this immunotherapy alone can control the cancer and delay its growth. About 60 participants will receive the drug unti…
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New hope for NMOSD: ofatumumab aims to slash relapse rate
Disease control Recruiting nowThis small pilot study tests whether ofatumumab can reduce the number of relapses in people with a rare autoimmune disease called NMOSD. Five adults who have had at least two relapses in the past two years will receive the drug. Researchers will track relapse rates and disability…
Phase: PHASE1, PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Could a simple steroid boost stroke recovery? new trial aims to find out
Disease control Recruiting nowThis study tests whether giving the steroid methylprednisolone right after a stroke clot removal procedure can help patients recover better and lower the risk of bleeding in the brain. About 210 adults who had a major stroke and had their blocked artery reopened will receive eith…
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Could a common supplement boost cancer therapy? new trial tests taurine with immunotherapy for stomach cancer.
Disease control Recruiting nowThis study tests whether adding the supplement taurine to a standard treatment (immunotherapy drug serplulimab plus chemotherapy) can improve outcomes for people with locally advanced stomach or gastroesophageal junction cancer. About 96 adults whose tumors have a specific marker…
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New drug cocktail aims to shrink tonsil tumors before surgery
Disease control Recruiting nowThis study tests whether giving a combination of two drugs (nimotuzumab and toripalimab) plus chemotherapy before surgery can help people with advanced tonsil cancer. The goal is to see if the tumors shrink or disappear completely, making surgery more effective. Ten adults with r…
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC
-
Could a simple steroid boost stroke recovery? major trial launches
Disease control Recruiting nowThis study tests whether giving the steroid methylprednisolone right after a stroke clot removal procedure can help patients recover better. About 1060 adults who had a major stroke from a blocked artery in the brain will receive either the steroid or a placebo through an artery …
Phase: PHASE3 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
Morning vs. evening infusion: could timing boost cancer treatment?
Disease control Recruiting nowThis study looks at whether giving immunotherapy at different times of day changes how well it works for people with a type of esophageal cancer. About 90 patients will get the same drug combination but at either morning or evening infusion times. The goal is to see if timing aff…
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC
-
New combo aims to keep advanced lung cancer in check
Disease control Recruiting nowThis study tests whether combining two drugs (adebrelimab and etoposide capsules) can help keep advanced small cell lung cancer from growing after initial chemotherapy. About 32 adults with extensive-stage disease who have not worsened after first treatment will receive this main…
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 09, 2026 12:09 UTC
-
New study aims to find best drug to stop eye weakness from spreading
Disease control Recruiting nowThis study looks at different immunosuppressant drugs in 200 adults with ocular myasthenia gravis (OMG), a condition causing eye muscle weakness. The goal is to see which treatment best controls symptoms and prevents the disease from spreading to other muscles. Researchers will t…
Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 08, 2026 13:17 UTC
-
New dissolvable stent could keep nasal polyps away after surgery
Disease control Recruiting nowThis study tests a special dissolvable stent that releases medicine inside the sinuses after surgery for nasal polyps. The goal is to see if it can stop polyps from coming back and reduce the need for steroid pills or sprays. About 192 adults with a type of nasal polyp linked to …
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 01, 2026 18:08 UTC
-
Brain injury patients may get gut relief from specialized liquid diet
Symptom relief Recruiting nowThis study looks at whether a special liquid diet (semi-elemental nutrition) can reduce stomach and bowel problems like vomiting, diarrhea, and bloating in people with severe traumatic brain injury. About 100 adults aged 18-75 will be randomly assigned to receive either the speci…
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Symptom relief
Last updated Jun 16, 2026 12:55 UTC
-
Could zapping the brain ease nerve pain for NMOSD patients?
Symptom relief Recruiting nowThis study is testing a non-invasive brain stimulation technique called tTIS to see if it can safely reduce nerve pain in people with neuromyelitis optica spectrum disorder (NMOSD). The trial will enroll 12 adults who have had nerve pain for at least 3 months. Researchers will me…
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Symptom relief
Last updated Jun 15, 2026 19:02 UTC
-
New study: ultrasound test may unlock hidden cause of infertility after C-Section
Knowledge-focused Recruiting nowThis study looks at 300 women who had a C-section and are now having trouble getting pregnant or have other symptoms. Researchers use a special ultrasound called saline infusion sonohysterography (SIS) to check the scar on the uterus. The goal is to see how well SIS finds scar de…
Sponsor: Tang-Du Hospital • Aim: Knowledge-focused
Last updated Jun 16, 2026 21:34 UTC
-
Blood thinners and baby hopes: new study investigates uterine health
Knowledge-focused Recruiting nowThis study looks at whether blood-thinning medications (like aspirin or heparin) can improve the uterine lining and pregnancy rates in women struggling with infertility. Researchers will use special ultrasound scans to measure the womb's thickness, blood flow, and movement in abo…
Sponsor: Tang-Du Hospital • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC